Advertisement
Review Article| Volume 54, P273-284, September 2020

What Is the Role of Neoadjuvant Radiation Therapy for Retroperitoneal Sarcoma?

      Retroperitoneal sarcoma presents a number of treatment challenges, including high rates of recurrence, even with aggressive, curative-intent surgical resection.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2018.
        CA Cancer J Clin. 2018; 68: 7-30
        • Clark M.A.
        • Fisher C.
        • Judson I.
        • et al.
        Soft-tissue sarcomas in adults.
        N Engl J Med. 2005; 353: 701-711
        • Brennan M.F.
        • Antonescu C.R.
        • Moraco N.
        • et al.
        Lessons learned from the study of 10,000 patients with soft tissue sarcoma.
        Ann Surg. 2014; 260 ([discussion: 421–2]): 416-421
        • Gronchi A.
        • Strauss D.C.
        • Miceli R.
        • et al.
        Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group.
        Ann Surg. 2016; 263: 1002-1009
        • Chouliaras K.
        • Senehi R.
        • Ethun C.G.
        • et al.
        Recurrence patterns after resection of retroperitoneal sarcomas: an eight-institution study from the US Sarcoma Collaborative.
        J Surg Oncol. 2019; 120: 340-347
        • Toulmonde M.
        • Bonvalot S.
        • Méeus P.
        • et al.
        Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
        Ann Oncol. 2014; 25: 735-742
        • Singer S.
        • Antonescu C.R.
        • Riedel E.
        • et al.
        Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
        Ann Surg. 2003; 238 ([discussion: 370–1]): 358-370
        • Stojadinovic A.
        • Leung D.H.Y.
        • Hoos A.
        • et al.
        Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.
        Ann Surg. 2002; 235: 424-434
        • Peacock O.
        • Patel S.
        • Simpson J.A.
        • et al.
        A systematic review of population-based studies examining outcomes in primary retroperitoneal sarcoma surgery.
        Surg Oncol. 2019; 29: 53-63
        • Bonvalot S.
        • Raut C.P.
        • Pollock R.E.
        • et al.
        Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.
        Ann Surg Oncol. 2012; 19: 2981-2991
        • Gronchi A.
        • Miceli R.
        • Colombo C.
        • et al.
        Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.
        Ann Oncol. 2012; 23: 1067-1073
        • Bonvalot S.
        • Miceli R.
        • Berselli M.
        • et al.
        Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.
        Ann Surg Oncol. 2010; 17: 1507-1514
        • Pisters P.W.T.
        Resection of some -- but not all -- clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas.
        J Clin Oncol. 2009; 27: 6-8
        • Crago A.M.
        Extended surgical resection and histology in retroperitoneal sarcoma.
        Ann Surg Oncol. 2015; 22: 1401-1403
        • Gronchi A.
        • Miceli R.
        • Allard M.A.
        • et al.
        Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.
        Ann Surg Oncol. 2015; 22: 1447-1454
        • Rosenberg S.A.
        • Tepper J.
        • Glatstein E.
        • et al.
        The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy.
        Ann Surg. 1982; 196: 305-315
        • Pisters P.W.
        • Harrison L.B.
        • Leung D.H.
        • et al.
        Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
        J Clin Oncol. 1996; 14: 859-868
        • Yang J.C.
        • Chang A.E.
        • Baker A.R.
        • et al.
        Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
        J Clin Oncol. 1998; 16: 197-203
        • Porter G.A.
        • Baxter N.N.
        • Pisters P.W.T.
        Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy.
        Cancer. 2006; 106: 1610-1616
        • Bates J.E.
        • Dhakal S.
        • Mazloom A.
        • et al.
        The benefit of adjuvant radiotherapy in high-grade nonmetastatic retroperitoneal soft tissue sarcoma: a SEER analysis.
        Am J Clin Oncol. 2018; 41: 274-279
        • Trovik L.H.
        • Ovrebo K.
        • Almquist M.
        • et al.
        Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
        Acta Oncol. 2014; 53: 1165-1172
        • Nussbaum D.P.
        • Speicher P.J.
        • Gulack B.C.
        • et al.
        Long-term oncologic outcomes after neoadjuvant radiation therapy for retroperitoneal sarcomas.
        Ann Surg. 2015; 262: 163-170
        • DeLaney T.F.
        • Chen Y.-L.
        • Baldini E.H.
        • et al.
        Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.
        Adv Radiat Oncol. 2017; 2: 85-93
        • Baldini E.H.
        • Wang D.
        • Haas R.L.M.
        • et al.
        Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel.
        Int J Radiat Oncol Biol Phys. 2015; 92: 602-612
        • Ballo M.T.
        • Zagars G.K.
        • Pollock R.E.
        • et al.
        Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.
        Int J Radiat Oncol Biol Phys. 2007; 67: 158-163
        • Bishop A.J.
        • Zagars G.K.
        • Torres K.E.
        • et al.
        Combined modality management of retroperitoneal sarcomas: a single-institution series of 121 patients.
        Int J Radiat Oncol Biol Phys. 2015; 93: 158-165
        • Zlotecki R.A.
        • Katz T.S.
        • Morris C.G.
        • et al.
        Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience.
        Am J Clin Oncol. 2005; 28: 310-316
        • Le Péchoux C.
        • Musat E.
        • Baey C.
        • et al.
        Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?.
        Ann Oncol. 2013; 24: 832-837
        • Jones J.J.
        • Catton C.N.
        • O’Sullivan B.
        • et al.
        Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma.
        Ann Surg Oncol. 2002; 9: 346-354
        • Pisters P.W.T.
        • Ballo M.T.
        • Fenstermacher M.J.
        • et al.
        Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.
        J Clin Oncol. 2003; 21: 3092-3097
        • Mak K.S.
        • Phillips J.G.
        • Barysauskas C.M.
        • et al.
        Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma.
        Pract Radiat Oncol. 2016; 6: 360-366
        • MacNeill A.J.
        • Miceli R.
        • Strauss D.C.
        • et al.
        Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group.
        Cancer. 2017; 123: 1971-1978
        • Raut C.P.
        • Callegaro D.
        • Miceli R.
        • et al.
        Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG.
        Clin Cancer Res. 2019; 25: 2664-2671
        • Molina G.
        • Hull M.A.
        • Chen Y.-L.
        • et al.
        Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma.
        J Surg Oncol. 2016; 114: 814-820
        • Lahat G.
        • Anaya D.A.
        • Wang X.
        • et al.
        Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches.
        Ann Surg Oncol. 2008; 15: 1585-1593
        • Fabre-Guillevin E.
        • Coindre J.-M.
        • Somerhausen Nde S.A.
        • et al.
        Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
        Cancer. 2006; 106: 2725-2733
        • Hull M.A.
        • Molina G.
        • Niemierko A.
        • et al.
        Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma.
        J Surg Oncol. 2017; 115: 746-751
        • Pawlik T.M.
        • Pisters P.W.T.
        • Mikula L.
        • et al.
        Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.
        Ann Surg Oncol. 2006; 13: 508-517
      1. Surgery with or without radiation therapy in treating patients with primary soft tissue sarcoma of the retroperitoneum or pelvis - Full text view - ClinicalTrials.gov.
        (Available at:) (Accessed August 22, 2019)
      2. Surgery with or without radiation therapy in untreated nonmetastatic retroperitoneal sarcoma - Full text view - ClinicalTrials.gov.
        (Available at:) (Accessed August 19, 2019)
        • Rastrelli M.
        • Raut C.
        • Chung P.
        • et al.
        • van Coevorden Stephan Stoldt Eberhard Stoeckle Piotr Rutkowski Claudia Sangalli Charles Honor SBAGCLPCJSDCSPMF
        STRASS (EORTC 62092): a phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma.
        (Available at:) (Accessed August 27, 2019)
        • Nussbaum D.P.
        • Rushing C.N.
        • Lane W.O.
        • et al.
        Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
        Lancet Oncol. 2016; 17: 966-975
        • Albertsmeier M.
        • Rauch A.
        • Roeder F.
        • et al.
        External beam radiation therapy for resectable soft tissue sarcoma: a systematic review and meta-analysis.
        Ann Surg Oncol. 2018; 25: 754-767
        • Bartlett E.K.
        • Roses R.E.
        • Meise C.
        • et al.
        Preoperative radiation for retroperitoneal sarcoma is not associated with increased early postoperative morbidity.
        J Surg Oncol. 2014; 109: 606-611
        • Nussbaum D.P.
        • Speicher P.J.
        • Gulack B.C.
        • et al.
        The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas.
        Surg Oncol. 2014; 23: 155-160
        • Casali P.G.
        • Abecassis N.
        • Bauer S.
        • et al.
        Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2018; 29: iv51-iv67
        • von Mehren M.
        • Randall R.L.
        • Benjamin R.S.
        • et al.
        Soft tissue sarcoma, version 2.2014.
        J Natl Compr Canc Netw. 2014; 12: 473-483
        • Berger N.G.
        • Silva J.P.
        • Mogal H.
        • et al.
        Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: an analysis of the National Cancer Data Base.
        Surgery. 2018; 163: 318-323
        • Bagaria S.P.
        • Neville M.
        • Gray R.J.
        • et al.
        The volume-outcome relationship in retroperitoneal soft tissue sarcoma: evidence of improved short- and long-term outcomes at high-volume institutions.
        Sarcoma. 2018; 2018: 3056562
        • Adam M.A.
        • Moris D.
        • Behren S.
        • et al.
        Hospital volume threshold for the treatment of retroperitoneal sarcoma.
        Anticancer Res. 2019; 39: 2007-2014
        • Haas R.L.
        • Baldini E.H.
        • Chung P.W.
        • et al.
        Radiation therapy in retroperitoneal sarcoma management.
        J Surg Oncol. 2018; 117: 93-98